VEGF with AMD3100 endogenously mobilizes mesenchymal stem cells and improves fracture healing

被引:19
作者
Meeson, Richard [1 ,2 ]
Sanghani-Keri, Anita [1 ]
Coathup, Melanie [1 ,3 ]
Blunn, Gordon [1 ,4 ]
机构
[1] Univ Coll London, Div Surg, Stanmore, Middx, England
[2] Royal Vet Coll, Hatfield, Herts, England
[3] Univ Cent Florida, Orlando, FL 32816 USA
[4] Univ Portsmouth, Portsmouth, Hants, England
基金
英国医学研究理事会;
关键词
mobilization; mesenchymal stem cells; AMD3100; VEGF; fracture healing; BONE-MARROW; PERIPHERAL-BLOOD; PROGENITOR CELLS; IN-VIVO; BIOLOGICAL CHARACTERISTICS; PRECURSOR CELLS; ANGIOGENESIS; MIGRATION; REPAIR; ANTAGONIST;
D O I
10.1002/jor.24164
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
A significant number of fractures develop non-union. Mesenchymal stem cell (MSC) therapy may be beneficial, however, this requires cell acquisition, culture and delivery. Endogenous mobilization of stem cells offers a non-invasive alternative. The hypothesis was administration of VEGF and the CXCR4 antagonist AMD3100 would increase the circulating pool of available MSCs and improve fracture healing. Ex-breeder female wistar rats received VEGF followed by AMD3100, or sham PBS. Blood prepared for culture and colonies were counted. P3 cells were analyzed by flow cytometry, bi-differentiation. The effect of mobilization on fracture healing was evaluated with 1.5 mm femoral osteotomy stabilized with an external fixator in 12-14 week old female Wistars. The mobilized group had significantly greater number of cfus/ml compared to controls, p = 0.029. The isolated cells expressed 1.8% CD34, 35% CD45, 61% CD29, 78% CD90, and differentiated into osteoblasts but not into adipocytes. The fracture gap in animals treated with VEGF and AMD3100 showed increased bone volume; 5.22 +/- 1.7 mu m(3) and trabecular thickness 0.05 +/- 0.01 mu m compared with control animals (4.3 +/- 3.1 mu m(3), 0.04 +/- 0.01 mu m, respectively). Radiographic scores quantifying fracture healing (RUST) showed that the animals in the mobilization group had a higher healing score compared to controls (9.6 vs. 7.7). Histologically, mobilization resulted in significantly lower group variability in bone formation (p = 0.032) and greater amounts of bone and less fibrous tissue than the control group. Clinical significance: This pre-clinical study demonstrates a beneficial effect of endogenous MSC mobilization on fracture healing, which may have translation potential to prevent or treat clinical fractures at risk of delayed or non-union fractures. (c) 2018 The Authors. Journal of Orthopaedic Research (R) Published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. J Orthop Res 37:1294-1302, 2019.
引用
收藏
页码:1294 / 1302
页数:9
相关论文
共 50 条
  • [1] CXCR4 Antagonist AMD3100 Promotes Mesenchymal Stem Cell Mobilization in Rats Preconditioned with the Hypoxia-Mimicking Agent Cobalt Chloride
    Liu, Lizhen
    Yu, Qin
    Fu, Shan
    Wang, Binsheng
    Hu, Kaimin
    Wang, Limengmeng
    Hu, Yongxian
    Xu, Yulin
    Yu, Xiaohong
    Huang, He
    STEM CELLS AND DEVELOPMENT, 2018, 27 (07) : 466 - 478
  • [2] AMD3100 improves ovariectomy-induced osteoporosis in mice by facilitating mobilization of hematopoietic stem/progenitor cells
    Im, Jin Young
    Min, Woo-Kie
    Park, Min Hee
    Kim, NamOh
    Lee, Jong Kil
    Jin, Hee Kyung
    Choi, Je-Yong
    Kim, Shin-Yoon
    Bae, Jae-sung
    BMB REPORTS, 2014, 47 (08) : 439 - 444
  • [3] Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture Healing
    Granero-Molto, Froilan
    Weis, Jared A.
    Miga, Michael I.
    Landis, Benjamin
    Myers, Timothy J.
    O'Rear, Lynda
    Longobardi, Lara
    Jansen, E. Duco
    Mortlock, Douglas P.
    Spagnoli, Anna
    STEM CELLS, 2009, 27 (08) : 1887 - 1898
  • [4] Significant mobilization of both conventional and regulatory T cells with AMD3100
    Kean, Leslie S.
    Sen, Sharon
    Onabajo, Olusegun
    Singh, Karnail
    Robertson, Jennifer
    Stempora, Linda
    Bonifacino, Aylin C.
    Metzger, Mark E.
    Promislow, Daniel E. L.
    Mattapallil, Joseph J.
    Donahue, Robert E.
    BLOOD, 2011, 118 (25) : 6580 - 6590
  • [5] The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model
    Wang, Xin
    Wang, Cheng
    Gou, Wenlong
    Xu, Xiaolong
    Wang, Yu
    Wang, Aiyuan
    Xu, Wenjing
    Guo, Quanyi
    Liu, Shuyun
    Lu, Qiang
    Meng, Haoye
    Yuan, Mei
    Peng, Jiang
    Lu, Shibi
    STEM CELL RESEARCH & THERAPY, 2018, 9
  • [6] Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes
    Lee, H. M.
    Wysoczynski, M.
    Liu, R.
    Shin, D-M
    Kucia, M.
    Botto, M.
    Ratajczak, J.
    Ratajczak, M. Z.
    LEUKEMIA, 2010, 24 (03) : 573 - 582
  • [7] AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo
    Yu, M.
    Gang, E. J.
    Parameswaran, R.
    Stoddart, S.
    Fei, F.
    Schmidhuber, S.
    Park, E.
    Hsieh, Y. T.
    Yang, A. S.
    Groffen, J.
    Heisterkamp, N.
    Kim, Y. M.
    BLOOD CANCER JOURNAL, 2011, 1 : e14 - e14
  • [8] AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse
    Samuelson, Clare
    Radtke, Stefan
    Cui, Margaret
    Perez, Anai
    Kiem, Hans-Peter
    Humbert, Olivier
    EXPERIMENTAL HEMATOLOGY, 2021, 93 : 52 - U21
  • [9] Effects of immune cells on mesenchymal stem cells during fracture healing
    Ehnert, Sabrina
    Relja, Borna
    Schmidt-Bleek, Katharina
    Fischer, Verena
    Ignatius, Anita
    Linnemann, Caren
    Rinderknecht, Helen
    Huber-Lang, Markus
    Kalbitz, Miriam
    Histing, Tina
    Nussler, Andreas K.
    WORLD JOURNAL OF STEM CELLS, 2021, 13 (11): : 1667 - 1695
  • [10] Plerixafor (AMD3100) induces prolonged mobilization of acute lymphoblastic leukemia cells and increases the proportion of cycling cells in the blood in mice
    Welschinger, Robert
    Liedtke, Florian
    Basnett, Jordan
    Dela Pena, Aileen
    Juarez, Julius G.
    Bradstock, Kenneth F.
    Bendall, Linda J.
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (03) : 293 - 302